Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Ali Valika , Maria Rosa Costanzo Added: 3 years ago
Sleep-disordered breathing (SDB) is common in heart failure (HF) patients and is associated with increased morbidity and mortality. Abnormal sleep patterns are often characterised by cycles of significant pauses in breathing and partial neurological arousals that lead to maladaptive neurohormonal activation. SDB is broadly classified into two types: obstructive sleep apnea (OSA) and central sleep… View more

Heart Failure
Long-term Outcome of Pulmonary Vein Isolation Versus Amiodarone Therapy in Patients with Coexistent Persistent AF and Congestive Heart Failure
Author(s): Michela Faggioni , Domenico G Della Rocca , Sanghamitra Mohanty , et al Added: 4 years ago
Heart failure with reduced ejection fraction (HFrEF) and AF share several predisposing risk factors and often coexist in the same population.1 Although AF can be a marker of worsening heart failure (HF), it can also be a main driver of disease progression. The presence of AF in patients with HFrEF is associated with an increased risk of stroke, re-hospitalisations and all-cause death.2 Therefore,… View more

Heart Failure

Electrophysiology & Arrhythmia
Wilhelm Haverkamp
Job title: Professor of Internal Medicine/Cardiology
Professor Dr. Wilhelm Haverkamp serves as a distinguished faculty member in the field of Internal Medicine and Cardiology at the Department of Cardiology, Charité – Campus Virchow, Humboldt University of Berlin, Germany. His journey in the medical realm commenced at the University of Münster, Germany, where he earned his M.D. degree with honors (magna cum laude). Dr. Haverkamp honed his skills in… View more
Author(s): Lampros Papadimitriou , Charles K Moore , Javed Butler , et al Added: 4 years ago
Heart failure (HF) is a global epidemic which affects about 6 million adults in the US. It is projected that by 2030 the total cost of HF will reach US$70 billion. Despite the development of novel drugs and devices, the mortality burden of HF remains high, with one in three patients dying within 1 year of hospitalisation for HF and 40–50% within 5 years of diagnosis.1 Patients with HF are… View more

Standards & Guidelines

Heart Failure
Fluid Management in Patients with Chronic Heart Failure
Author(s): Pierpaolo Pellicori , Kuldeep Kaur , Andrew L Clark Added: 3 years ago
Heart failure (HF) is one of the most common reasons for admission to hospital. It is associated with long in-patient stays, and has a high in-hospital and post-discharge morbidity and mortality, whether left ventricular ejection fraction (LVEF) is reduced (HFREF) or normal (HeFNEF).1,2 Congestion, or fluid overload, is a classic clinical feature of patients presenting with HF. In some patients,… View more

Heart Failure

Prevention & Chronic Conditions
Is Medication Titration in Heart Failure too Complex?
Author(s): John J Atherton , Annabel Hickey Added: 3 years ago
The prevalence of heart failure (HF) continues to rise, driven by an ageing population, increasing rates of obesity and diabetes, and better survival in patients with cardiovascular disease.1 While HF is associated with substantial morbidity and mortality, a number of treatments have been shown to improve outcomes in large-scale randomised controlled trials (RCT), including pharmacological… View more

Heart Failure
José P Henriques
Job title: Director of the Catheterisation Laboratory
Dr José P Henriques is Director of the Catheterisation Laboratory at the Academic Medical Centre of the University of Amsterdam. He also leads the Academic Medical Centre Mechanical support for Acute Congestive Heart failure in ST elevation myocardial infarction (STEMI) patients (AMC MACH) programme. Dr Henriques gained his MD from the University of Amsterdam and his PhD in medicine from the… View more
Dilemmas in the Dosing of HFrEF Drugs: Titrating Diuretics in Chronic Heart
Author(s): David Pham , Justin L Grodin Added: 3 years ago
Introduction Advances in heart failure medical therapy over the past few decades have improved the prognosis of patients with this condition. Despite this, heart failure remains a significant burden to the medical system as the incidence of heart failure hospitalisation continues to rise.1 Diuretics have been a mainstay of therapy in heart failure to relieve congestion and improve symptoms… View more

Heart Failure
Author(s): Jackson J Liang , David J Callans Added: 3 years ago
As the population ages, the incidence of both AF and heart failure (HF) will continue to increase. By the year 2030, there will be an estimated >12 million patients with AF and >8 million patients with HF.1,2 A significant proportion of patients with HF have reduced (<50%) left ventricular ejection fraction (heart failure with reduced ejection fraction, HFrEF) and the coexistance of AF… View more

Heart Failure

Electrophysiology & Arrhythmia
Author(s): Mohammad S Alzahri , Anita Rohra , W Frank Peacock Added: 3 years ago
Acute heart failure (AHF) presents symptoms primarily the result of pulmonary congestion due to elevated left ventricular (LV) filling pressures with or without reduced ejection fraction (EF). Common precipitating pathology includes coronary artery disease (CAD), hypertension and valvular heart diseases, in addition to other noncardiac conditions, such as diabetes, anaemia and kidney dysfunction… View more

Heart Failure

MI/ACS